Miscibility Behavior and Formation Mechanism of Stabilized Felodipine-Polyvinylpyrrolidone Amorphous Solid Dispersions

In the present study, solid dispersion systems of felodipine (FEL) with polyvinylpyrrolidone (PVP) were developed, in order to enhance solid state stability and release kinetics. The prepared systems were characterized by using Differential Scanning Calorimetry, X-Ray Diffraction, and Scanning Electron Microscopy techniques, while the interactions which take place were identified by using Fourier Transformation-Infrared Spectroscopy. Due to the formation of hydrogen bonds between the carbonyl group of PVP and the amino groups of FEL, transition of FEL from crystalline to amorphous state was achieved. The dispersion of FEL was found to be in nano-scale particle sizes and dependent on the FEL/PVP ratio. This modification leads to partial miscibility of the two components, as it was verified by DSC and optimal glass dispersion of FEL into the polymer matrix since no crystalline structure was detected with XRD. The above deformation has a significant effect on the dissolution enhancement and the release kinetics of FEL, as it causes the pattern to change from linear to logarithmic. An impressive optimization of the dissolution profile is observed corresponding to a rapid release of FEL in the system containing 10% w/w of FEL, releasing 100% in approximately 20 min. The particle size of dispersed FEL into PVP matrix could be classified as the main parameter affecting dissolution optimization. The mechanism of such enhancement consists of the lower energy required for the dissolution due to the amorphous transition and the fine dispersion, which leads to an optimal contact surface of the drug substance with the dissolution media. The prepared systems are stable during storage at 40 ± 1°C and relative humidity of 75 ± 5%. Addition of sodium docusate as surfactant does not affect the release kinetics, but only the initial burst due to its effect on the surface tension and wettability of the systems.

[1]  A. Juppo,et al.  Evaluation of controlled-release polar lipid microparticles. , 2002, International journal of pharmaceutics.

[2]  D. Craig,et al.  The mechanisms of drug release from solid dispersions in water-soluble polymers. , 2002, International journal of pharmaceutics.

[3]  H. Kristensen,et al.  The effect of α-tocopherol on the in vitro solubilisation of lipophilic drugs , 2001 .

[4]  G Zografi,et al.  How does residual water affect the solid-state degradation of drugs in the amorphous state? , 1996, Journal of pharmaceutical sciences.

[5]  S. Srčič,et al.  SOME PHYSICOCHEMICAL PROPERTIES OF GLASSY FELODIPINE , 1991 .

[6]  Ying Ku Lin,et al.  Investigations on the drug releasing mechanism from an asymmetric membrane-coated capsule with an in situ formed delivery orifice. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[7]  H. Colom,et al.  A comparative in vitro study of transdermal absorption of a series of calcium channel antagonists. , 1991, Journal of pharmaceutical sciences.

[8]  Anant Paradkar,et al.  Characterization of curcumin-PVP solid dispersion obtained by spray drying. , 2004, International journal of pharmaceutics.

[9]  Dimitrios N. Bikiaris,et al.  Hydrophilic matrices as carriers in felodipine solid dispersion systems , 2001 .

[10]  B. Abrahamsson,et al.  Evaluation of Solubilizers in the Drug Release Testing of Hydrophilic Matrix Extended-Release Tablets of Felodipine , 1994, Pharmaceutical Research.

[11]  C. Regårdh,et al.  Pharmacokinetics and haemodynamic effects of felodipine as monotherapy in hypertensive patients. , 1987, Clinical and investigative medicine. Medecine clinique et experimentale.

[12]  F. Ponce-Gordo,et al.  The effect of solubilization on the oral bioavailability of three benzimidazole carbamate drugs. , 2004, International journal of pharmaceutics.

[13]  D. Giron Impact of Solid State Reactions on Medicaments , 1988 .

[14]  A. Juppo,et al.  Evaluation of polar lipid-hydrophilic polymer microparticles. , 2003, International journal of pharmaceutics.

[15]  D. A. Shapiro,et al.  Extended‐release felodipine in patients with mild to moderate hypertension , 1994, Clinical pharmacology and therapeutics.

[16]  P. Parrini,et al.  Thermal behavior and dissolution properties of naproxen from binary and ternary solid dispersions. , 1999, Drug development and industrial pharmacy.

[17]  N A Peppas,et al.  Bimodal drug release achieved with multi-layer matrix tablets: transport mechanisms and device design. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[18]  E. Squillante,et al.  Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. , 2004, International journal of pharmaceutics.

[19]  J. Ford The use of Thermal Analysis in the Study of Solid Dispersions , 1987 .

[20]  George Zografi,et al.  Physical Properties of Solid Molecular Dispersions of Indomethacin with Poly(vinylpyrrolidone) and Poly(vinylpyrrolidone-co-vinyl-acetate) in Relation to Indomethacin Crystallization , 1999, Pharmaceutical Research.

[21]  A. Serajuddin,et al.  Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. , 1999, Journal of pharmaceutical sciences.

[22]  Ž. Knez,et al.  Micronization of drugs using supercritical carbon dioxide. , 1999, International journal of pharmaceutics.

[23]  S. Srčič,et al.  Investigation of felodipine polymorphism and its glassy state , 1992 .

[24]  B. Edgar,et al.  Bioavailability from felodipine extended-release tablets with different dissolution properties , 1990 .

[25]  C. Panayiotou,et al.  Blends of polymers with similar glass transition temperatures: A DMTA and DSC study , 2004 .

[26]  Keiji Sekiguchi,et al.  Studies on Absorption of Eutectic Mixture. I. A Comparison of the Behavior of Eutectic Mixture of Sulfathiazole and that of Ordinary Sulfathiazole in Man. , 1961 .

[27]  D. Horn,et al.  Chromatographic study of interactions between polyvinylpyrrolidone and drugs. , 1982, Journal of pharmaceutical sciences.

[28]  Bruno C. Hancock,et al.  The Relationship Between the Glass Transition Temperature and the Water Content of Amorphous Pharmaceutical Solids , 1994, Pharmaceutical Research.

[29]  Z. Otwinowski,et al.  Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[30]  Margarita Valero,et al.  Effect of PVP K-25 on the formation of the naproxen:β-ciclodextrin complex , 2003 .

[31]  Björn Lemmer,et al.  Circadian rhythms and drug delivery , 1991 .

[32]  T. Fox Influence of Diluent and of Copolymer Composition on the Glass Temperature of a Poly-mer System , 1956 .

[33]  P Augustijns,et al.  Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[34]  L Yu,et al.  Amorphous pharmaceutical solids: preparation, characterization and stabilization. , 2001, Advanced drug delivery reviews.